The DOI matches its Crossref record; 48 of the 51 references it cites were found in a registry or an index.
Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6
Abstract
Cytokine-specific alterations of monoamine activity were evident in the hypothalamus, hippocampus and prefrontal cortex 2 h following peripheral administration of recombinant interleukin (IL)-1 beta, IL-2 and IL-6 (200 ng, i.p.) in male, BALB/c mice. IL-1 induced the broadest range of neurochemical changes, affecting central norepinephrine (NE), serotonin (5-HT) and dopamine (DA) activity. In particular, IL-1 enhanced NE turnover in the hypothalamus and hippocampus, 5-HT turnover in the hippocampus and prefrontal cortex (owing to increased utilization and reduced content of the transmitters in these brain regions), and enhanced DA utilization in the prefrontal cortex. IL-6 increased 5-HT and DA activity in the hippocampus and prefrontal cortex in a manner similar to IL-1, but failed to affect central NE activity. Moreover, IL-2 increased hypothalamic NE turnover (reflecting a profound increase in NE utilization) and enhanced DA turnover in the prefrontal cortex, but did not influence central 5-HT activity. Hence, these cytokines differentially altered neurochemical activity in brain regions that mediate neuroimmune interactions and that are influenced by physical and psychological stressors. In addition to the neurochemical changes, plasma corticosterone concentrations were profoundly enhanced in IL-1-treated animals, but not significantly altered by IL-2 or IL-6 treatment. The IL-1-induced corticosterone elevations did not significantly correlate with alterations of hypothalamic NE activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Proinflammatory cytokines significantly affect the peripheral and central 5-HT systems.”
From Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness? (2016) · cites this paper as [43]
In the citing paper
“Peripheral injections of IL-1 increase NA turnover in the hypothalamus and hippocampus, 5-HT turnover in the hippocampus and prefrontal cortex, and DA turnover in the prefrontal cortex[43].”
From Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness? (2016) · cites this paper as [43]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504
Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151
Release of Multiple Hormones by a Direct Action of Interleukin-1 on Pituitary Cells
Bernton, E. W., Beach, J. E., Holaday, J. W., Smallridge, R. C., & Fein, H. G. (1987) · Science · doi:10.1126/science.2821620 · Cited by 671
The immune system as a sensory organ.
Blalock, J. E. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.3.1067 · Cited by 551
Catecholaminergic Modulation of Corticotropin-Releasing Factor and Adrenocorticotropin Secretion
Plotsky, P. M., Cunningham, E. T., & Widmaier, E. P. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-4-437 · Cited by 530
Immunoregulation mediated by the sympathetic nervous system
Besedovsky, H. O., del Rey, A., Sorkin, E., Prada, M. D., & Keller, H. H. (1979) · Cellular Immunology · doi:10.1016/0008-8749(79)90129-1 · Cited by 488
The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells
Denicoff, K. D., RUBINOW, D. R., PAPA, M. Z., SIMPSON, C., SEIPP, C. A., LOTZE, M. T., Chang, A. E., ROSENSTEIN, D., & Rosenberg, S. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-293 · Cited by 456
The Immune Response Evokes Changes in Brain Noradrenergic Neurons
Besedovsky, H. O., del Rey, A., Sorkin, E., Prada, M. D., Burri, R., & Honegger, C. G. (1983) · Science · doi:10.1126/science.6867729 · Cited by 445
Stress and the Mesocorticolimbic Dopamine Systemsa
ROTH, R. H., TAM, S., IDA, Y., YANG, J., & DEUTCH, A. Y. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb42102.x · Cited by 342
Research works printed but not linked: 3
- Saphier, 1993, Central nervous system effects of α-interferon, Res. Persp. Psychoneuroimmunol., IV, A
- Zalcman, 1993, IL-2-induced potentiation of immune, function is mediated by the sympathetic nervous system, Soc. Neurosci. Abstr., 19, 945
- Zalcman, 1991, Alterations of central catecholamines associated with primary and secondary immunological challenge, Soc. Neurosci. Abstr., 17, 1202
Cited by
Sorted by citations
Items 201–300 of 439
DONFRANCESCO, R., NATIVIO, P., BORRELLI, E., Eleonora, G. I. U. A., ANDRIOLA, E., VILLA, M. P., & TRANI, M. D. (2021) · Minerva Pediatrics · doi:10.23736/s2724-5276.16.04642-9 · Cited by 44
Effect of serotonin on cytokine mRNA expression in rat hippocampal astrocytes
Pousset, F., Fournier, J., Legoux, P., Keane, P., Shire, D. J., & Soubrié, P. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00324-l · Cited by 44
Patel, A., Zhu, Y., Kuzhikandathil, E. V., Banks, W. A., Siegel, A., & Zalcman, S. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041623 · Cited by 43
Self-citationAltered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia
An, H.-M., Tan, Y.-L., Shi, J., Wang, Z.-R., Soars, J. C., Wu, J. Q., Yang, F.-D., Huang, X., & Zhang, X. Y. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.037 · Cited by 42
Motta, C., Finardi, A., Toniolo, S., Lorenzo, F. D., Scaricamazza, E., Loizzo, S., Mercuri, N. B., Furlan, R., Koch, G., & Martorana, A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191250 · Cited by 44
Emudainohwo, J. O. T., Ben‐Azu, B., Adebayo, O. G., Aduema, W., Uruaka, C. I., Ajayi, A. M., Okpakpor, E. E., & Ozolua, R. I. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02084-w · Cited by 46
Bhatt, S., Zalcman, S. S., Hassanain, M., & Siegel, A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.065 · Cited by 42
Self-citationCOX-2 inhibitors as adjunctive therapy in schizophrenia
Müller, N., Strassnig, M., Schwarz, M., Ulmschneider, M., & Riedel, M. J. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.8.1033 · Cited by 41
Differences in cytokines between patients with generalised anxiety disorder and panic disorder
Zou, Z., Zhou, B., Huang, Y., Wang, J., Min, W., & Li, T. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.109975 · Cited by 41
Laurentiis, A. D., Pisera, D. A., Caruso, C. M., Candolfi, M., Mohn, C. E., Rettori, V., & Seilicovich, A. (2002) · NeuroImmunoModulation · doi:10.1159/000064412 · Cited by 40
Kasckow, J. W., Regmi, A., Gill, P. S., Parkes, D. G., & Geracioti, T. D. (1997) · Endocrinology · doi:10.1210/endo.138.11.5543 · Cited by 40
Ugwu, P. I., Ben‐Azu, B., Ugwu, S. U., Uruaka, C. I., Nworgu, C. C., Okorie, P. O., Okafor, K. O., Anachuna, K. K., Elendu, M. U., Ugwu, A. O., et al. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.03.004 · Cited by 40
Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence
Šakić, B., Lacosta, S., Denburg, J. A., & Szechtman, H. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00171-6 · Cited by 39
The impact of inflammation on neurocognition and risk for psychosis: a critical review
Kogan, S., Ospina, L. H., Mittal, V. A., & Kimhy, D. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01073-2 · Cited by 38
Jaehne, E. J., Corrigan, F., Toben, C. G., Jawahar, M. C., & Baune, B. T. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.05.021 · Cited by 40
Interleukin-2 modulates N-methyl-d-aspartate receptors of native mesolimbic neurons
Ye, J. H., Tao, L., & Zalcman, S. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02056-x · Cited by 38
Self-citationRasheed, N., Tyagi, E., Ahmad, A., Siripurapu, K. B., Lahiri, S., Shukla, R., & Palit, G. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.01.035 · Cited by 37
Rossi‐George, A., Urbach‐Ross, D., Colas-Zelin, D. C., Goldfarb, Y., & Kusnecov, A. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0687-05.2005 · Cited by 37
Tumor necrosis factor-α gene promoter polymorphisms in chronic schizophrenia
Tan, E., Chong, S., Tan, C., Teo, Y., Peng, K., & Mahendran, R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00345-7 · Cited by 37
Hudson, S. P., Jacobson‐Pick, S., & Anisman, H. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.007 · Cited by 35
Self-citationPetitto, J. M., Huang, Z., Raizada, M. K., Rinker, C. M., & McCarthy, D. B. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00276-3 · Cited by 36
Longitudinal study of inflammatory markers and psychopathology in schizophrenia
Feng, T., McEvoy, J. P., & Miller, B. J. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.10.003 · Cited by 35
Manning, J., Kulbida, R., Rai, P., Jensen, L. G., Bouma, J. E., Singh, S. P., O’Malley, D., & Yilmazer‐Hanke, D. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.079475 · Cited by 37
Cytokines in parvovirus b19 infection as an aid to understanding chronic fatigue syndrome
Kerr, J. R., & Tyrrell, D. A. J. (2003) · Current Pain and Headache Reports · doi:10.1007/s11916-003-0031-3 · Cited by 35
Involvement of Neuropeptide Systems in Schizophrenia: Human Studies
Cáceda, R., Kinkead, B. L., & Nemeroff, C. B. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78011-4 · Cited by 33
Acharjee, S., Branton, W. G., Vivithanaporn, P., Maingat, F. G., Paul, A. M., Dickie, P., Baker, G. B., & Power, C. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.02.016 · Cited by 34
Zhang, X. Y., Zhou, D. F., Cao, L. Y., Zhang, P. Y., & Wu, G. Y. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00023-7 · Cited by 34
MicroRNA 142-3p Mediates Post-Transcriptional Regulation of D1 Dopamine Receptor Expression
Tobón, K. E., Chang, D., & Kuzhikandathil, E. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049288 · Cited by 33
Müller, N., & Bechter, K. (2013) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2013.04.004 · Cited by 37
Miller, B. J., Buckley, P. F., & McEvoy, J. P. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.08.027 · Cited by 35
Murray, C. A., Clements, M., & Lynch, M. A. (1999) · Gerontology · doi:10.1159/000022076 · Cited by 34
Bencsik, A. A., Malcus, C., Akaoka, H., Giraudon, P., Belin, M., & Bernard, A. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00173-5 · Cited by 33
Zádor, F., Nagy-Grócz, G., Kékesi, G., Dvorácskó, S., Szűcs, E., Tömböly, C., Horváth, G., Benyhe, S., & Vécsei, L. (2019) · Molecules · doi:10.3390/molecules24203709 · Cited by 33
Adiposity, inflammation, and working memory: Evidence for a vicious cycle
Shields, G. S., Deer, L. K., Hastings, P. D., & Hostinar, C. E. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100202 · Cited by 32
Neuroimmune mechanisms in health and disease: 1. Health.
Anisman, H., Baines, M. G., Berczi, I., Bernstein, C. N., Blennerhassett, M. G., Gorczynski, R. M., Greenberg, A. H., Kisil, F. T., Mathison, R. D., Nagy, E., et al. (1996) · Europe PMC (PubMed Central) · Cited by 32
Self-citationMiller, B. J., Herzig, K., Jokelainen, J. J., Karhu, T., Keinanen-Kiukaanniemi, S. M., Järvelin, M., Veijola, J. M., Viinamäki, H. T., Tanskanen, P., Jääskeläinen, E., et al. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01134-x · Cited by 31
Oprica, M., Zhu, S., Goiny, M., Pham, T. M., Mohammed, A. H. S., Winblad, B. G., Bartfai, T., & Schultzberg, M. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.07.006 · Cited by 32
Behavioral and neurochemical responses in mice bearing tumors submitted to social stress
Vegas, Ó., Beitia, G., Sánchez‐Martín, J. R., Arregi, A., & Azpiroz, A. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.04.006 · Cited by 31
Reyes, T. M., & Coe, C. L. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00038-0 · Cited by 31
Lack of Evidence for a Role of Serotonin in Interleukin-1–Induced Hypophagia
Swiergiel, A. H., & Dunn, A. J. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00225-7 · Cited by 31
Pawlak, C. R., Schwarting, R. K. W., & Bauhofer, A. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.03.002 · Cited by 31
Development and Adult Plasticity of Serotoninergic Neurons and Their Target Cells
Azmitia, E. C., & Whitaker‐Azmitia, P. M. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60921-3_1 · Cited by 30
Misener, V. L., Schachar, R. J., Ickowicz, A., MALONE, M. A., Roberts, W., Tannock, R., Kennedy, J. L., Pathare, T., & Barr, C. L. (2004) · Neuropsychobiology · doi:10.1159/000079976 · Cited by 29
Karrenbauer, B. D., Müller, C. P., Ho, Y., Spanagel, R., Huston, J. P., Schwarting, R. K. W., & Pawlak, C. R. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.05.011 · Cited by 30
Abdoli, A., & Dalimi, A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00339 · Cited by 30
Gasparotto, O. C., Lopes, D. M., & Carobrez, S. G. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.06.014 · Cited by 28
Animal Models Recapitulating the Multifactorial Origin of Tourette Syndrome
Macrì, S., Onori, M. P., Roessner, V., & Laviola, G. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00008-1 · Cited by 28
Petitto, J. M., & Huang, Z. L. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00229-9 · Cited by 27
Novel alternative promoters of mouse glial cell line-derived neurotrophic factor gene
Tanaka, M., Ito, S., & Kiuchi, K. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00218-9 · Cited by 27
Foucart, S., & Abadie, C. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168699 · Cited by 27
Is There Evidence for an Effect of Antidepressant Drugs on Immune Function?
Neveu, P. J., & Castanon, N. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-0-585-37970-8_15 · Cited by 26
Rengasamy, M. L., Marsland, A. L., Spada, M. L., Hsiung, K. S., Kovats, T., & Price, R. B. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100177 · Cited by 29
Central metabolite changes and activation of microglia after peripheral interleukin-2 challenge
Schneider, P., Weber‐Fahr, W., Schweinfurth, N., Ho, Y., Sartorius, A., Spanagel, R., & Pawlak, C. R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.09.011 · Cited by 25
Song, C., Earley, B., & Leonard, B. E. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)00073-x · Cited by 25
IL-2/15 receptor-β gene deletion alters neurobehavioral performance
Petitto, J. M., Huang, Z. L., Hartemink, D. A., & Beck, R. D. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03393-5 · Cited by 25
Anderson, K. K., Ballok, D. A., Prasad, N., Szechtman, H., & Šakić, B. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.07.030 · Cited by 25
Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders
Nayeri, T., Sarvi, S., & Daryani, A. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00824-2 · Cited by 24
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Mancini, M., Natoli, S., Gardoni, F., Luca, M. D., & Pisani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065618 · Cited by 24
Sleep regulation: Interactions among cytokines and classical neurotransmitters
Simoni, M. G. D., Imeri, L., Matteo, W. D., Perego, C., Simard, S., & Terrazzino, S. (1995) · Advances in Neuroimmunology · doi:10.1016/0960-5428(95)00008-p · Cited by 24
Yang, X., Zhao, H., Liu, X., Xie, Q., Zhou, X., Deng, Q., & Wang, G. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.594766 · Cited by 22
Cao, L., Hudson, C. A., & Moynihan, J. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.03.003 · Cited by 25
van Hooijdonk, C. F. M., van der Pluijm, M., Bosch, I., van Amelsvoort, T., Booij, J., de Haan, L., Selten, J., & van de Giessen, E. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.12.008 · Cited by 21
Zhang, D., Patel, A., Zhu, Y., Siegel, A., & Zalcman, S. S. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.01.005 · Cited by 22
Self-citationBroderick, P. A. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00301-9 · Cited by 22
Circulating brain-reactive autoantibodies and behavioral deficits in the MRL model of CNS lupus
Williams, S., Sakic, B., & Hoffman, S. A. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.10.008 · Cited by 22
Genetic Basis of Positive and Negative Symptom Domains in Schizophrenia
Xavier, R. M., & Vorderstrasse, A. A. (2017) · Biological Research For Nursing · doi:10.1177/1099800417715907 · Cited by 22
Petitto, J. M., Meola, D., & Huang, Z. L. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-071-7_15 · Cited by 22
Modeling the role of infections in the etiology of mental illness
Pearce, B. D. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00098-7 · Cited by 21
Cytokines and Cognitive Function in Mice
Bianchi, M., Sacerdote, P., & Panerai, A. E. (1998) · Neurosignals · doi:10.1159/000014527 · Cited by 22
Fleshner, M., Silbert, L. H., Terrence Deak, B., Goehler, L. E., Martin, D. A., Watkins, L. R., & MAIER, S. F. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00258-x · Cited by 21
Захарова, Л. А., Malyukova, I. V., Proshlyakova, E. V., Потапова, А. А., Sapronova, A. Y., Ершов, П. В., & Ugrumov, M. V. (2000) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(00)00057-7 · Cited by 21
Linthorst, A. C. E., & Reul, J. M. H. M. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-0-585-37970-8_9 · Cited by 21
Calefi, A. S., Fonseca, J. G. D. S., Nunes, C. A. D. Q., Lima, A. P., Quinteiro-Filho, W. M., Flório, J. C., Zager, A., Ferreira, A. J. P., & Palermo‐Neto, J. (2019) · Veterinary Sciences · doi:10.3390/vetsci6010004 · Cited by 20
Müller, N., Riedel, M. J., Schwarz, M., Gruber, R., & Ackenheil, M. (1997) · Key topics in brain research · doi:10.1007/978-3-7091-6870-7_8 · Cited by 20
Time-dependent in vivo mesolimbic dopamine variations following antigenic challenge
Lacosta, S., Merali, Z., Zalcman, S. S., & Anisman, H. (1994) · Brain Research · doi:10.1016/0006-8993(94)91976-3 · Cited by 19
Self-citationLow-grade chronic inflammation induces behavioral stereotypy in rats
Erbaş, O., Akseki, H. S., Aktuğ, H., & Taşkıran, D. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9630-4 · Cited by 18
Is there an immunologic basis for schizophrenia?
Leonard, B. E. (2005) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.1.1.103 · Cited by 18
Immunoregulation by the sympathetic nervous system
Nance, D. M., & Macneil, B. J. (2001) · Neuroimmune biology · doi:10.1016/s1567-7443(01)80013-2 · Cited by 18
Self-citationPlata‐Saláman, C. R., Wilson, C. D., & ffrench-Mullen, J. M. H. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00126-0 · Cited by 18
Associations between immunological function and memory recall in healthy adults
Wang, G., Taylor, T., Sumich, A. L., Mérien, F., Borotkanics, R., Wrapson, W., Krägeloh, C., & Siegert, R. J. (2017) · Brain and Cognition · doi:10.1016/j.bandc.2017.10.002 · Cited by 17
Cytokines, neurophysiology, neuropsychology, and psychiatric symptoms.
Schwarz, M. (2003) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2003.5.2/mschwarz · Cited by 19
Experimental Evaluation of an Altered Tryptophan Metabolism in Fibromyalgia
Schwarz, M., Offenbächer, M., Neumeister, A., & Ackenheil, M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_30 · Cited by 16
Lukáts, B., Egyed, R., Lénárd, L., & Karádi, Z. (2005) · Appetite · doi:10.1016/j.appet.2005.03.014 · Cited by 17
Pae, C., Kim, J.-J., Yu, H.-S., Lee, C., Lee, S.-J., Jun, T., Lee, C., & Paik, I. (2004) · Neuropsychobiology · doi:10.1159/000076718 · Cited by 16
Xiu, M. H., Man, L., Wang, D., Du, X., Yin, G., Zhang, Y., Tan, Y., Chen, N., Chen, S., Teixeira, A. L., et al. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32622 · Cited by 16
The role of IL-6 in TBI and PTSD, a potential therapeutic target?
Monsour, M., Croci, D. M., & Agazzi, S. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107280 · Cited by 18
Prenatal Alcohol Exposure: Impact on Neuroendocrine–Neuroimmune Networks
Bodnar, T. S., & Weinberg, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_10 · Cited by 19
The immune system can affect learning: chronic immune complex disease in a rat model
Hoffman, S. A., Shucard, D. W., & Harbeck, R. J. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00052-6 · Cited by 16
The Impact of Soluble Interleukin-2 Receptor as a Biomarker of Delirium
Baranyi, A., & Rothenhäusler, H. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.06.004 · Cited by 15
Changes of Cytokines in Children With Tic Disorder
Tao, Y., Xu, P., Zhu, W., Chen, Z., Tao, X., Liu, J., Xue, Z., Zhu, T., & Jiang, P. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.800189 · Cited by 15
Peroza, L. R., Schaffer, L. F., de Freitas, C. M., Leal, C. Q., Ferrari, M. C., Duarte, M. M. F. M., & Fachinetto, R. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1961-6 · Cited by 15
Psychiatric Disorders - Worldwide Advances
Uehara, T. (2011) · InTech eBooks · doi:10.5772/1289 · Cited by 16
Self-Stimulation from the Mesencephalon Following Intraventricular Interleukin-2 Administration
Hebb, A. L. O., Zacharko, R. M., & Anisman, H. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00447-4 · Cited by 15
Self-citationReddaway, J., & Brydges, N. M. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103567 · Cited by 17
Time-dependent effects of striatal interleukin-2 on open field behaviour in rats
Karrenbauer, B. D., Ho, Y., Ludwig, V., Löhn, J., Spanagel, R., Schwarting, R. K. W., & Pawlak, C. R. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.003 · Cited by 14
In-vitro Immunomodulatory Effects of Haloperidol and Perazine in Schizophrenia
Kowalskl, J., Blada, P., Kucia, K. A., Lawniczek, T., Madej, A., Belowski, D., & Herman, Z. S. (2000) · The World Journal of Biological Psychiatry · doi:10.3109/15622970009150591 · Cited by 14
Ecstasy (MDMA) in Recreational Users: Self-Reported Psychological and Physiological Effects
DAVISON, D., & Parrott, A. C. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199705/06)12:3 · Cited by 134
Longitudinal study of inflammation and relapse in schizophrenia
Miller, B. J., Lemos, H. D. P., Schooler, N. R., GOFF, D. C., Kopelowicz, A. J., Lauriello, J., Manschreck, T. C., Mendelowitz, A. J., Miller, D. D., Severe, J. B., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2022.12.028 · Cited by 13
Li, R., Hou, J., Xu, Q., Liu, Q., Shen, Y.-J., Rodin, G., & Li, M. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9270-x · Cited by 13
Metadata
- Authors
- Zalcman, S., Green-Johnson, J. M., Murray, L., Nance, D. M., Dyck, D., Anisman, H., & Greenberg, A. H.
- Affiliations
- University of Manitoba (CA)
- Carleton University (CA)
- Corresponding author
- Greenberg, Arnold H.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 1994-04
- Volume
- 643
- Issue
- 1-2
- Pages
- 40-49
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2082698695
- Cited by
- 439
- References
- 51
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 11 · 2022: 13 · 2021: 12 · 2020: 11 · 2019: 17 · 2018: 13 · 2017: 14 · 2016: 12 · 2015: 7 · 2014: 19 · 2013: 14 · 2012: 18
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH043778, MH-43778-04A2)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- IL-1β, interleukin-2, interleukin-6, cytokines, monoamines, norepinephrine turnover, serotonin turnover, dopamine turnover, hypothalamus, hippocampus, prefrontal cortex, neuroimmune interactions, corticosterone, stress response
- MeSH terms
- Animals, Brain, Chromatography, High Pressure Liquid, Corticosterone, Dopamine, Hippocampus, Humans, Hydroxyindoleacetic Acid, Hypothalamus, Interleukin-1, Interleukin-2, Male, Methoxyhydroxyphenylglycol, Mice, Inbred BALB C, Norepinephrine, Recombinant Proteins, Reference Values, 3,4-Dihydroxyphenylacetic Acid, Biogenic Monoamines, Interleukin-6, Prefrontal Cortex, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review